Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...

Scientists conducting medical research are facing an existential crisis: Layoffs and budget cuts pushed by President Trump ...

Pancreatic cancer vaccines eliminate disease in preclinical studies Pancreatic cancer has a five-year survival rate of just 13%, making it the deadliest cancer, according to the American Cancer ...

A NEW vaccine could cure up to half of all pancreatic cancer cases and may one day wipe out the disease entirely, scientists say. Pancreatic cancer is the deadliest cancer in the world. Some 10,500… ...

In this week’s edition of InnovationRx, we look at Immuneering’s slow-and-steady approach to cancer fighting, litigation over ...

The vaccine is designed to be given in three doses and could be used both as a treatment and a preventive measure, especially for patients at high risk of developing pancreatic cancer.

As part of a clinical trial, the National Center for Tumor Diseases (NCT/UCC) Dresden is now offering patients with ...

Using a newly discovered byproduct of dying cancer cells, University of Wisconsin–Madison researchers are developing personalized vaccines that could help keep aggressive tumors from recurring.

The vaccine uses nanoparticles containing antigens to target and destroy malignant cells. It has achieved incredible results, with more than half of the preclinical models of pancreatic ductal ...

06/24/2025 11:40 Only Site in Saxony: NCT/UCC Dresden Offers Personalized mRNA Vaccine for Pancreatic Cancer Anne Vetter Presse- und Öffentlichkeitsarbeit Nationales Centrum für ...